Markers of study quality were examined [9 (link)] and strengths and limitations of the studies are presented along with propensity for bias. The latter was examined using a modified Cochrane Collaboration approach for assessing risk of bias.[10 ] We focused on three main domains in relation to our study objectives—selection bias (eg whether those who were already in care were excluded from linkage to care outcome calculations), outcome ascertainment (eg whether objective measures such as clinic records were sought to determine LTC) and attrition (with a cut-off of ≥20% loss-to-follow up as high attrition)—before summarising if the risk of bias in a study was low, medium or high overall. Studies were not excluded for quality reasons using formal criteria for reporting scientific data, not least because a large proportion of the available data came from operational delivery of HTC services and authors presented data as were available from the programmes.
Ethical approval was not required as only published literature was included for review.